Results: 732

Trametinib and dabrafenib induced rhabdomyolysis, renal failure, and visual loss. Report of one case

Rev. méd. Chile; 148 (11), 2020
ABSTRACT MEK- and BRAF-inhibitors trametinib and dabrafenib are successfully used for BRAF-mutated, metastasizing melanoma, but these compounds may induce side effects. We report a 50 years old female with BRAF-mutated metastasizing melanoma who received trametinib (2 mg/d) and dabrafenib (200 mg/d) afte...

Resección laparoscópica de metástasis intestinales de melanoma maligno

Rev. cir. (Impr.); 72 (5), 2020
Resumen Objetivos: El melanoma cutáneo presenta un alto potencial metastásico y constituye la fuente extraabdominal más frecuente de lesión del intestino delgado. El diagnóstico de metástasis gastrointestinales es a menudo una expresión de enfermedad avanzada, con una supervivencia media de entre...

Spitz nevus and infliximab: association or coincidence?

An. bras. dermatol; 95 (5), 2020
Abstract Biological therapies, including anti-TNF agents, are important in the treatment of various chronic inflammatory diseases, including psoriasis, rheumatoid arthritis or inflammatory bowel disease. The increased use of these drugs translates into an increasing awareness of its adverse effects, whic...

Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome

An. bras. dermatol; 95 (5), 2020
Abstract Pilomatricomas are benign tumors originating from the capillary matrix, which may present as solitary lesions or, less commonly, multiple. Myotonic dystrophy and familial adenomatous polyposis are the most frequently associated disorders with multiple pilomatricomas. There are few reports relati...

Outcome of staged excision with pathologic margin control in high-risk basal cell carcinoma of the head region

An. bras. dermatol; 95 (5), 2020
Abstract Background: High-risk basal cell carcinoma involves a significant rate of basal cell carcinoma that requires Mohs micrographic surgery for definitive treatment. Staged excision with pathologic margin control is a simple, accessible, and curative procedure suggested for the treatment of high-ris...

Immunohistochemical analysis of S100-positive epidermal Langerhans cells in dermatofibrom

An. bras. dermatol; 95 (5), 2020
Abstract Dermatofibroma is a dermal fibrohistiocytic neoplasm. The Langerhans cells are the immunocompetent cells of the epidermis, and they represent the first defense barrier of the immune system towards the environment. The objective was to immunohistologically compare the densities of S100-positive L...

Profile of the use of dermoscopy among dermatologists in Brazil (2018)

An. bras. dermatol; 95 (5), 2020
Abstract Background: Dermoscopy increases the diagnostic accuracy in dermatology. The aspects related to training, usage profile, or perceptions of usefulness of dermoscopy among dermatologists in Brazil have not been described. Objectives: To evaluate the profile of the use of dermoscopy and the perce...

Case for diagnosis. Penile lesion in HIV-negative patient

An. bras. dermatol; 95 (5), 2020
Abstract We present the case of an HIV-negative man with asymptomatic penile erythematoviolaceous papules associated with similar slightly verrucous papules in the interdigital space of the right foot. A biopsy of the penile lesion confirmed Kaposi's sarcoma. No other causes of immunosuppression were obs...

Comparison of basal cell carcinoma subtypes observed in preoperative biopsy and Mohs micrographic surgery

An. bras. dermatol; 95 (5), 2020
Abstract Background: The treatment of basal cell carcinoma depends on its histological subtype. Therefore, a biopsy should be performed before definitive treatment. However, as the biopsy is only a sample of the tumor, it does not always shows every histological subtype present in the neoplasm. Few stud...